Amylyx Pharmaceuticals prices upsized $500M public offering of common
· seekingalpha.com
Amylyx Pharmaceuticals (AMLX) announced the pricing of an upsized underwritten public offering of 14.09M shares of common stock at $35.50 per share. The company also granted underwriters a 30-day option to buy up to an additional 2.11M shares.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...